ORIGINAL RESEARCH
Published on 09 Apr 2024
A disproportionality analysis of FDA adverse event reporting system (FAERS) events for ticagrelor
doi 10.3389/fphar.2024.1251961
- 2,617 views
- Frontiers in Pharmacology
- Pharmacoepidemiology
- Research Topics
- Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety
Pharmacovigilance and Pharmacoepidemiology: Public Health and Safety
11k
Total Downloads
45k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 27 Mar 2024
Detection of iodixanol-induced allergic reaction signals in Chinese inpatients: a multi-center retrospective database study using prescription sequence symmetry analysis
doi 10.3389/fphar.2024.1298021
- 639 views
ORIGINAL RESEARCH
Published on 31 Jan 2024
Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the FDA adverse event reporting system
doi 10.3389/fphar.2024.1280201
- 1,962 views
- 4 citations
ORIGINAL RESEARCH
Published on 21 Dec 2023
Drug-induced QT prolongation and torsade de pointes: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database
doi 10.3389/fphar.2023.1259611
- 3,593 views
- 7 citations
ORIGINAL RESEARCH
Published on 19 Dec 2023
Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
doi 10.3389/fphar.2023.1301120
- 2,753 views
- 1 citation
ORIGINAL RESEARCH
Published on 22 Nov 2023
Dose-response association of metformin use and risk of age-related macular degeneration among patients with type 2 diabetes mellitus: a population-based study
doi 10.3389/fphar.2023.1275095
- 1,199 views
ORIGINAL RESEARCH
Published on 16 Nov 2023
Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes
doi 10.3389/fphar.2023.1284287
- 1,481 views
- 3 citations
ORIGINAL RESEARCH
Published on 30 Oct 2023
Cardiovascular risk of Janus kinase inhibitors compared with biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis without underlying cardiovascular diseases: a nationwide cohort study
doi 10.3389/fphar.2023.1165711
- 3,011 views
- 4 citations
ORIGINAL RESEARCH
Published on 26 Oct 2023
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
doi 10.3389/fphar.2023.1259908
- 3,183 views
- 6 citations
ORIGINAL RESEARCH
Published on 02 Oct 2023
Infections associated with clozapine: a pharmacovigilance study using VigiBase®
doi 10.3389/fphar.2023.1260915
- 2,524 views
- 1 citation
ORIGINAL RESEARCH
Published on 12 Jul 2023
Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database
doi 10.3389/fphar.2023.1182113
- 3,464 views
- 6 citations
ORIGINAL RESEARCH
Published on 11 Jul 2023
Active surveillance and clinical analysis of anaphylaxis based on the China Hospital Pharmacovigilance System
doi 10.3389/fphar.2023.1180685
- 1,523 views
- 2 citations
Published in
Frontiers in Pharmacology
- Pharmacoepidemiology
Impact
- 45kTopic views
- 32kArticle views
- 11kArticle downloads